37 top medical experts on Lethal Midline Granuloma across 5 countries and 3 U.S. states, including 7 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Lethal Midline Granuloma: A condition that is characterized by inflammation, ulceration, and perforation of the nose and the palate with progressive destruction of midline facial structures. This syndrome can be manifested in several diseases including the nasal type of extranodal NK-T-cell lymphoma and granulomatosis with polyangiitis.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Nose Diseases (3,953).
  4. Synonyms: Granuloma Gangraenescens,  Polymorphic Reticulosis


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Neumann, Julia E   Google Publications
    Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. .
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  2. Schüller, Ulrich   Google Publications
    Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. .
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  3. Stone, John H   Rheumatology  Google Publications
    Division of Rheumatology, Allergy, & Immunology, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Physician  Case Reports 
    Disclosed payments in 2021 from 12 biomedical companies, totalling $22,954.4, including $10,736.25 from  SANOFI-AVENTIS U.S. LLC
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

  4. Deshpande, Vikram   Anatomic Pathology & Clinical Pathology  Google Publications
    Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Physician  Case Reports 
    Medical school: Other (MD, 1989)
    Medicare Accepted
    Disclosed payments from biomedical company (Takeda Pharmaceuticals U.S.A., Inc.) in 2021 for $10,075
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

  5. Della-Torre, Emanuel  Google Publications
    Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA Unit of Medicine and Clinical Immunology, Università Vita-Salute San Raffaele, Milan, Italy. Top Hospital
    Scientist  Case Reports 
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

  6. Dorostkar, Mario M  Google Publications
    Center for Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  7. Giese, Armin  Google Publications
    Center for Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  8. Glatzel, Markus  Google Publications
    Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  9. Herms, Jochen  Google Publications
    Center for Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  10. Iglauer, Peter  Google Publications
    Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  11. Mawrin, Christian  Google Publications
    Institute of Neuropathology, University Hospital Magdeburg, Magdeburg, Germany.
    Scientist 
    Subjects: Brain Neoplasms; Glioma; Granuloma, Lethal Midline; Histones; Receptor, Fibroblast Growth Factor, Type 1
    Categories: Genetics; Pathology
    Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. (2021)

  12. Mahajan, Vinay S   Clinical Pathology  Google Publications
    Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Physician  Case Reports 
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

  13. Parker, Noah P   Orthopaedic Surgery  Google Publications
    Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, MN, USA. Top Hospital
    Physician 
    Disclosed payments in 2021 from 5 biomedical companies, totalling $6,289.06, including $6,147.84 from  Inspire Medical Systems, Inc.
    Subjects: Granuloma, Lethal Midline
    Categories: Diagnosis
    The dilemma of midline destructive lesions: a case series and diagnostic review. (2010)

  14. Kern, Robert C   Otolaryngology  Google Publications
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86.9/100
    Disclosed payments in 2021 from 15 biomedical companies, totalling $8,004.88, including $4,550 from  GlaxoSmithKline, LLC.
    Subjects: Granuloma, Lethal Midline
    Categories: Diagnosis
    The dilemma of midline destructive lesions: a case series and diagnostic review. (2010)

  15. Li, Dong Ming   Google Publications
    Department of Dermatology, Research Center for Medical Mycology, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing 100191, China.
    Scientist  Case Reports 
    Subjects: Granuloma, Lethal Midline; Mucor
    Categories: Isolation & Purification; Microbiology
    Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature. (2012)

  16. Lun, Li De  Google Publications
    Scientist  Case Reports 
    Subjects: Granuloma, Lethal Midline; Mucor
    Categories: Isolation & Purification; Microbiology
    Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature. (2012)

  17. Krause, Donald  Google Publications
    Rheumatology Service, St. Joseph Healthcare, Bangor, Maine, USA.
    Scientist  Case Reports 
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

  18. Mattoo, Hamid  Google Publications
    Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Scientist  Case Reports 
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

  19. Pillai, Shiv  Google Publications
    Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Scientist  Case Reports 
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

  20. Song, Philip   Dermatology  Google Publications
    Department of Otolaryngology, Massachusetts Eye & Ear Infirmary, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Physician  Case Reports 
    Subjects: Granuloma, Lethal Midline; Immunoglobulin G
    Categories: Immunology
    IgG4-related midline destructive lesion. (2014)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);